Virseda-Rodríguez A J, Salvatierra C, García F, Sanz A, Gutiérrez E, Serrano J M, Valverde S, Polo C, Amón-Sesmero J H, Rodríguez V, Cortiñas R, Calleja J, Adriazola M, Gala L, Bermúdez R, Moya I, Szczesniewski R J, López-Aramburu M A, Gómez-Veiga F
Complejo Asistencial Universitario de Salamanca y Grupo de Investigaciones Traslacionales en Urología IBSAL-GITUR, Salamanca, España.
Complejo Asistencial Universitario de Salamanca y Grupo de Investigaciones Traslacionales en Urología IBSAL-GITUR, Salamanca, España.
Actas Urol Esp (Engl Ed). 2018 Nov;42(9):593-599. doi: 10.1016/j.acuro.2017.10.002. Epub 2017 Dec 29.
To determine the actual incidence of prostate cancer (PC) in the healthcare areas of Castilla-Leon in 2014.
A multicentre study was conducted with the participation of 7 of the 9 healthcare areas of Castilla-Leon. We collected retrospective data that included 87.8% of the target population (men diagnosed with PC with histopathological confirmation in 2014). We calculated the raw and age-adjusted incidence rates based on the direct method and consulted the community and national epidemiological data in the Spanish National Institute of Statistics.
A total of 1198 new cases of PC were diagnosed, with a raw incidence rate in the community of 109.54 cases per 100,000 men. The adjusted rates for the Spanish and European populations were 115.41 and 110.07, respectively. The age group with the highest diagnostic concentration was the 60-70-year group, with 41.97% of the diagnoses. The group with the highest incidence was the 70-80-year group, with 438.87 cases per 100,000 inhabitants. There were differences in the raw and age-adjusted incidence rates and in the age at diagnosis among the various included healthcare areas.
The community raw incidence rate was higher than most existing data. We observed significant differences among the various geographical areas, which could be explained mainly by the age distribution and the opportunistic screening policies for each area.
确定2014年卡斯蒂利亚-莱昂自治区医疗保健区域内前列腺癌(PC)的实际发病率。
开展了一项多中心研究,卡斯蒂利亚-莱昂自治区9个医疗保健区域中的7个参与其中。我们收集了回顾性数据,这些数据涵盖了目标人群的87.8%(2014年经组织病理学确诊为前列腺癌的男性)。我们基于直接法计算了粗发病率和年龄调整发病率,并查阅了西班牙国家统计局的社区和国家流行病学数据。
共确诊1198例前列腺癌新病例,社区粗发病率为每10万名男性中有109.54例。西班牙人群和欧洲人群的调整发病率分别为115.41和110.07。诊断集中度最高的年龄组为60 - 70岁组,占诊断病例的41.97%。发病率最高的组为70 - 80岁组,每10万居民中有438.87例。纳入的各个医疗保健区域在粗发病率、年龄调整发病率以及诊断年龄方面存在差异。
社区粗发病率高于大多数现有数据。我们观察到不同地理区域之间存在显著差异,这主要可由各区域的年龄分布和机会性筛查政策来解释。